Sara B. Bloch

Glostrup, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmology.

Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmology.

Journal: Acta ophthalmologica

Published: February 18, 2015

Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting.

Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting.

Journal: Acta ophthalmologica

Published: April 04, 2014

Implementation studies of ranibizumab for neovascular age-related macular degeneration.

Implementation studies of ranibizumab for neovascular age-related macular degeneration.

Journal: Acta ophthalmologica

Published: November 12, 2013

A 4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degeneration.

A 4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degeneration.

Journal: Ophthalmology

Published: February 08, 2013

Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab.

Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab.

Journal: American journal of ophthalmology

Published: September 22, 2012

Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment.

Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment.

Journal: Acta ophthalmologica

Published: October 20, 2011

Treatment of wet age-related macular degeneration with vascular endothelial growth factor. A survey of a Cochrane review

Treatment of wet age-related macular degeneration with vascular endothelial growth factor. A survey of a Cochrane review

Journal: Ugeskrift for laeger

Published: November 21, 2009

Central serous chorioretinopathy

Central serous chorioretinopathy

Journal: Ugeskrift for laeger

Published: June 07, 2008

New treatment of age-related macular degeneration. The Danish Society of Ophthalmology

New treatment of age-related macular degeneration. The Danish Society of Ophthalmology

Journal: Ugeskrift for laeger

Published: April 10, 2008

Showing 1-9 of 9

Last Updated: 09/26/2026